Twin Securities »

Cerevel Therapeutics Hldng I shares owned by Twin Securities

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Twin Securities from 13F filings

Historical chart of Twin Securities investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Twin Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Twin Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.9M 233k 42.40

More positions owned by Twin Securities

Karuna Therapeutics Ord
United States Steel Corporation Call Option (X)
Cerevel Therapeutics Hldng I (CERE)
stock
Endeavor Group Hldgs Cl A Com (EDR)
ImmunoGen
Kenvue (KVUE)
Pioneer Natural Resources (PXD)

View all positions for Twin Securities

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I